A Study of TAS1440 With ATRA in Subjects With r/r AML

Clinical trial NCT04282668 · TERMINATED

Trial details

NCT number: NCT04282668
Sponsor: Taiho Oncology, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2020-03-15
Primary completion: 2024-02-12
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.